Additionally, blocking TREM-1 activity suppresses the migration of HCC cells during the early stages of carcinogenesis, particularly in response to conditioned media (CM) from HSC-derived cancer-associated myofibroblasts (CAMFs). Here, TREM1 is linked to cancer.